Literature DB >> 16772095

Predictors of failure to complete treatment for latent tuberculosis infection.

Armen E Parsyan1, Jussi Saukkonen, M Anita Barry, Sharon Sharnprapai, C Robert Horsburgh.   

Abstract

OBJECTIVE: Low rates of completion of treatment for latent tuberculosis infection (LTBI) limit its usefulness as a strategy for elimination of tuberculosis (TB) in the United States. This retrospective cohort study assessed predictors of completion of LTBI treatment among patients seen at an urban United States TB clinic in 1998.
METHODS: A retrospective cohort study of acceptance and completion of LTBI treatment among patients first seen in a TB clinic in 1998 was performed.
RESULTS: Of 2621 persons with a positive tuberculosis skin test (TST), 1723 were offered treatment and 1572 (91.2%) accepted. Of the 1572 who accepted, treatment was completed by 607 (38.6%). Of those persons who failed to complete treatment, 517/965 (54%) dropped out before the end of the first month of the course. Among 1375 persons under 35 years of age who initiated LTBI treatment, failure to complete was associated with birth in Haiti (OR=2.17, CI(95%) 1.49-3.17) or the Dominican Republic (OR=1.93, CI(95%) 1.08-3.43).
CONCLUSION: These results suggest that country-specific cultural and behavioral factors may contribute to failure to complete LTBI treatment, and that interventions to increase completion should focus on the first month after initiation.

Entities:  

Mesh:

Year:  2006        PMID: 16772095     DOI: 10.1016/j.jinf.2006.04.010

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  18 in total

1.  Predictors of latent tuberculosis infection treatment completion in the United States: an inner city experience.

Authors:  Y Hirsch-Moverman; J Bethel; P W Colson; J Franks; W El-Sadr
Journal:  Int J Tuberc Lung Dis       Date:  2010-09       Impact factor: 2.373

2.  Tuberculosis knowledge, attitudes, and beliefs in foreign-born and US-born patients with latent tuberculosis infection.

Authors:  Paul W Colson; Julie Franks; Rita Sondengam; Yael Hirsch-Moverman; Wafaa El-Sadr
Journal:  J Immigr Minor Health       Date:  2010-12

3.  Can a peer-based intervention impact adherence to the treatment of latent tuberculous infection?

Authors:  Y Hirsch-Moverman; P W Colson; J Bethel; J Franks; W M El-Sadr
Journal:  Int J Tuberc Lung Dis       Date:  2013-09       Impact factor: 2.373

Review 4.  A scoping review of paediatric latent tuberculosis infection care cascades: initial steps are lacking.

Authors:  Jeffrey I Campbell; Thomas J Sandora; Jessica E Haberer
Journal:  BMJ Glob Health       Date:  2021-05

5.  Predictors of latent tuberculosis treatment initiation and completion at a U.S. public health clinic: a prospective cohort study.

Authors:  Neela D Goswami; Lara Beth Gadkowski; Carla Piedrahita; Deborah Bissette; Marshall Alex Ahearn; Michela L M Blain; Truls Østbye; Jussi Saukkonen; Jason E Stout
Journal:  BMC Public Health       Date:  2012-06-21       Impact factor: 3.295

6.  Predictors of adherence to isoniazid preventive therapy among HIV positive adults in Addis Ababa, Ethiopia.

Authors:  Mesele Mindachew; Amare Deribew; Fasil Tessema; Sibhatu Biadgilign
Journal:  BMC Public Health       Date:  2011-12-12       Impact factor: 3.295

7.  Tuberculosis Prevention in the Private Sector: Using Claims-Based Methods to Identify and Evaluate Latent Tuberculosis Infection Treatment With Isoniazid Among the Commercially Insured.

Authors:  Erica L Stockbridge; Thaddeus L Miller; Erin K Carlson; Christine Ho
Journal:  J Public Health Manag Pract       Date:  2018 Jul/Aug

8.  Self-reported Engagement in Care among U.S. Residents with Latent Tuberculosis Infection: 2011-2012.

Authors:  James D Mancuso; Roque Miramontes; Carla A Winston; C Robert Horsburgh; Andrew N Hill
Journal:  Ann Am Thorac Soc       Date:  2021-10

9.  Beyond pills and tests: addressing the social determinants of tuberculosis.

Authors:  Tom Wingfield; Marco A Tovar; Doug Huff; Delia Boccia; Matthew J Saunders; Sumona Datta; Rosario Montoya; Eric Ramos; James J Lewis; Robert H Gilman; Carlton Evans
Journal:  Clin Med (Lond)       Date:  2016-12       Impact factor: 2.659

10.  Completion of treatment for latent tuberculosis infection with monthly drug dispensation directly through the tuberculosis clinic.

Authors:  Claudia C Dobler; Guy B Marks
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.